At what pace is the bartonellosis market growing, and what is its estimated value?
The bartonellosis market size has grown rapidly in recent years. It will grow from $1.17 billion in 2024 to $1.31 billion in 2025 at a compound annual growth rate (CAGR) of 12.0%. The growth in the historic period can be attributed to the increasing prevalence of Bartonella disease, increasing healthcare expenditure, rising funding for research and development, rising prevalence of transmissible illnesses, and increasing prevalence of infectious diseases.
The bartonellosis market size is expected to see rapid growth in the next few years. It will grow to $2.03 billion in 2029 at a compound annual growth rate (CAGR) of 11.7%. The growth in the forecast period can be attributed to the rise in incidences of zoonotic diseases, rising disease awareness, a growing number of pet owners, a growing emphasis on personalized medicine, and increasing awareness of cat scratch disease. Major trends in the forecast period include advances in medical technology, advancements in biotechnology, the development of combined testing, advances in diagnostic methods, and ongoing research and development.
Get Your Free Sample of The Global Bartonellosis Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21111&type=smp
What are the top drivers to the rising demand in the bartonellosis market?
The rise in incidences of zoonotic diseases is expected to propel the growth of the bartonellosis market going forward. Zoonotic diseases are illnesses that are transmitted from animals to humans, either directly or through vectors. The rise in incidences of zoonotic diseases are due to factors such as increased human-animal interactions, environmental changes, deforestation, global travel, and the spread of pathogens across species. Bartonellosis supports zoonotic diseases by serving as a key example of how bacterial pathogens transmitted through animal vectors, such as fleas, ticks, and lice, can infect humans, leading to a range of clinical manifestations and highlighting the importance of understanding vector-borne disease transmission in public health. For instance, in January 2023, according to the report published by the Government of Canada, a Canada-based federal authority, there were 159 rabies samples submitted in November 2022, up from 135 rabies samples submitted in October 2022. Therefore, the rise in incidences of zoonotic diseases is driving the growth of the bartonellosis market.
How is the bartonellosis market segmented?
The bartonellosis market covered in this report is segmented –
1) By Disease Type: Cat Scratch Disease (CSD), Trench Fever, Bartonella Endocarditis, Other Disease Types
2) By Diagnostic Method: Polymerase Chain Reaction (PCR) Testing, Serological Testing, Culture Methods, Histological Testing
3) By Treatment: Antibiotics, Antibacterial Agents, Supportive Care
4) By End-User: Hospitals And Clinics, Diagnostic Laboratories, Other End-Users
Subsegments:
1) By Cat Scratch Disease (CSD): Immunocompetent Hosts, Immunocompromised Hosts, Neurological Complications
2) By Trench Fever: Acute Trench Fever, Chronic Trench Fever, Asymptomatic Infections
3) By Bartonella Endocarditis: Native Valve Endocarditis, Prosthetic Valve Endocarditis, Bloodstream Infections
4) By Other Disease Types: Bacillary Angiomatosis, Parinaud’s Oculoglandular Syndrome, Bartonella-associated Vasculitis
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/bartonellosis-global-market-report
Who are the top competitors in the bartonellosis market?
Major companies operating in the bartonellosis market are Mayo Clinic Laboratories, Northwell Health Labs, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, IDEXX Laboratories Inc., Bio-Rad Laboratories Inc., Alberta Precision Laboratories, Jiangsu BioPerfectus Technologies Co. Ltd., ARUP Laboratories, Surmodics Inc., Medical Diagnostic Laboratories LLC, Creative Biolabs, IGeneX Inc., Karius Inc., Synnovis Group LLP, Galaxy Diagnostics Inc., Gold Standard Diagnostics, Eurofins Biomnis, AMMAGENOMICS Private Limited, Ringbio
What significant trends should we anticipate in the bartonellosis market over the forecast period?
Major companies operating in the bartonellosis market are focusing on fundraising efforts to improve early detection and enhance therapeutic options for the disease. Fundraising efforts involve initiatives by organizations to raise funds that support the research, diagnosis, treatment, and prevention of bartonellosis, playing a vital role in driving innovation and improving access to healthcare solutions for the disease. For instance, in April 2022, the Global Lyme Alliance (GLA), a US-based nonprofit organization, launched a crowdfunding campaign aimed at raising $300,000 for groundbreaking research on Bartonella, a hidden pathogen that can cause serious health issues, including neuroinflammation and psychiatric disorders. This initiative coincided with Lyme disease awareness month and seeks to enhance understanding of Bartonella’s behavior in the body, which is crucial for developing more effective treatments for both Bartonella infections and related conditions like Lyme disease. The campaign emphasizes the need for increased awareness and funding to support those affected by these debilitating diseases.
Which regional trends are influencing the bartonellosis market, and which area dominates the industry?
North America was the largest region in the bartonellosis market in 2024. The regions covered in the bartonellosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Bartonellosis Market Report 2025 Offer?
The bartonellosis market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Bartonellosis is a bacterial infection caused by the Bartonella genus, impacting the skin, lymph nodes, and internal organs. Early diagnosis and antibiotic treatment are essential to prevent severe systemic complications and ensure effective disease management.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21111
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
